Search Results - "Marchand, Mathilde"

Refine Results
  1. 1

    Modelling recycling for the life cycle assessment of perovskite/silicon tandem modules by Wang, Lu, Oberbeck, Lars, Marchand Lasserre, Mathilde, Perez-Lopez, Paula

    ISSN: 2105-0716, 2105-0716
    Published: EDP Sciences 2024
    Published in EPJ Photovoltaics (2024)
    “…With the massive growth of the global capacity of photovoltaics (PV) over the last decade, the PV waste is expected to increase dramatically in the near…”
    Get full text
    Journal Article
  2. 2

    Time-dependent population PK models of single-agent atezolizumab in patients with cancer by Marchand, Mathilde, Zhang, Rong, Chan, Phyllis, Quarmby, Valerie, Ballinger, Marcus, Sternheim, Nitzan, Wu, Benjamin, Jin, Jin Y., Bruno, René

    ISSN: 0344-5704, 1432-0843, 1432-0843
    Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2021
    Published in Cancer chemotherapy and pharmacology (01.08.2021)
    “…Purpose The time-varying clearance (CL) of the PD-L1 inhibitor atezolizumab was assessed on a population of 1519 cancer patients (primarily with non-small-cell…”
    Get full text
    Journal Article
  3. 3

    Application of Zinc-Based Metal-Organic Framework ZIF-8 on Paper: A Pilot Study on Visual Appearance and Effectiveness by Balliana, Eleonora, Marchand, Mathilde, Di Matteo, Valentina, Ballarin, Barbara, Cassani, Maria Cristina, Panzavolta, Silvia, Zendri, Elisabetta

    ISSN: 2073-4360, 2073-4360
    Published: Switzerland MDPI AG 16.05.2025
    Published in Polymers (16.05.2025)
    “…Paper and cellulose-based materials are known for their sensitivity to humidity, which can create stresses among fibres and increase fragility. More…”
    Get full text
    Journal Article
  4. 4

    Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework by Shemesh, Colby S, Chan, Phyllis, Marchand, Mathilde, Gonçalves, Antonio, Vadhavkar, Shweta, Wu, Benjamin, Li, Chunze, Jin, Jin Y, Hack, Stephen P, Bruno, Rene

    ISSN: 1532-6535, 1532-6535
    Published: United States 01.09.2023
    Published in Clinical pharmacology and therapeutics (01.09.2023)
    “…We assess the longitudinal tumor growth inhibition (TGI) metrics and overall survival (OS) predictions applied to patients with advanced biliary tract cancer…”
    Get more information
    Journal Article
  5. 5

    Comparison of two‐stage and joint TGI‐OS modeling using data from six atezolizumab clinical studies in patients with metastatic non‐small cell lung cancer by Gonçalves, Antonio, Marchand, Mathilde, Chan, Phyllis, Jin, Jin Y., Guedj, Jérémie, Bruno, René

    ISSN: 2163-8306, 2163-8306
    Published: United States John Wiley & Sons, Inc 01.01.2024
    “…Two‐stage and joint modeling approaches are the two main approaches to investigate the link between longitudinal tumor size data and overall survival (OS) and…”
    Get full text
    Journal Article
  6. 6

    Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two‐stage approaches by Marchand, Mathilde, Gonçalves, Antonio, Mercier, François, Chanu, Pascal, Jin, Jin Y., Guedj, Jérémie, Bruno, René

    ISSN: 2163-8306, 2163-8306
    Published: United States John Wiley & Sons, Inc 01.06.2024
    “…Model‐based tumor growth inhibition (TGI) metrics are increasingly used to predict overall survival (OS) data in Phase III immunotherapy clinical trials…”
    Get full text
    Journal Article
  7. 7

    Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework by Chan, Phyllis, Marchand, Mathilde, Yoshida, Kenta, Vadhavkar, Shweta, Wang, Nina, Lin, Alyse, Wu, Benjamin, Ballinger, Marcus, Sternheim, Nitzan, Jin, Jin Y., Bruno, René

    ISSN: 2163-8306, 2163-8306
    Published: United States John Wiley & Sons, Inc 01.10.2021
    “…The objectives of the study were to use tumor size data from 10 phase II/III atezolizumab studies across five solid tumor types to estimate tumor growth…”
    Get full text
    Journal Article
  8. 8

    Population Pharmacokinetics and Exposure‐Response of Subcutaneous Atezolizumab in Patients With Non‐Small Cell Lung Cancer by Chan, Phyllis, Liu, Stephanie N., Gosselin, Nathalie, Sauve, Zacharie, Marchand, Mathilde, Lin, Alyse, Herraez‐Baranda, Luis, Zanghi, James, Shearer‐Kang, Esther, Liu, Xiaoyan, Wu, Benjamin, Chanu, Pascal

    ISSN: 2163-8306, 2163-8306
    Published: United States John Wiley & Sons, Inc 01.04.2025
    “…ABSTRACT IMscin001 is a two‐part dose‐finding (Phase Ib) and ‐confirmation (Phase III) study to evaluate atezolizumab pharmacokinetics of subcutaneous (SC)…”
    Get full text
    Journal Article
  9. 9

    Validation of Hourly Global Horizontal Irradiance for Two Satellite-Derived Datasets in Northeast Iraq by Ameen, Bikhtiyar, Balzter, Heiko, Jarvis, Claire, Wey, Etienne, Thomas, Claire, Marchand, Mathilde

    ISSN: 2072-4292, 2072-4292
    Published: Basel MDPI AG 01.10.2018
    Published in Remote sensing (Basel, Switzerland) (01.10.2018)
    “…Several sectors need global horizontal irradiance (GHI) data for various purposes. However, the availability of a long-term time series of high quality in situ…”
    Get full text
    Journal Article
  10. 10

    Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B‐cell non‐Hodgkin lymphoma by Bender, Brendan, Li, Chi‐Chung, Marchand, Mathilde, Turner, David C., Li, Feifei, Vadhavkar, Shweta, Wang, Bei, Deng, Rong, Lu, James, Jin, Jin, Li, Chunze, Yin, Shen, Wei, Michael, Chanu, Pascal

    ISSN: 1752-8054, 1752-8062, 1752-8062
    Published: United States John Wiley & Sons, Inc 01.06.2024
    Published in Clinical and translational science (01.06.2024)
    “…Mosunetuzumab (Mosun) is a CD20xCD3 T‐cell engaging bispecific antibody that redirects T cells to eliminate malignant B cells. The approved step‐up dose…”
    Get full text
    Journal Article
  11. 11

    Psychological evaluation of candidates for the uterus transplantation French trial by Karpel, Léa, Nicaise, Margaux, Carbonnel, Marie, Le Marchand, Mathilde, Racowsky, Catherine, Pirtea, Paul, Ayoubi, Jean‐Marc

    ISSN: 0001-6349, 1600-0412, 1600-0412
    Published: United States John Wiley & Sons, Inc 01.03.2025
    “…Introduction Since 2017, women with absolute uterine infertility due to Mayer‐Rokitansky‐Küster‐Hauser (MRKH) syndrome have been eligible to participate in a…”
    Get full text
    Journal Article
  12. 12

    Does climate help modeling COVID-19 risk and to what extent? by Scabbia, Giovanni, Sanfilippo, Antonio, Mazzoni, Annamaria, Bachour, Dunia, Perez-Astudillo, Daniel, Bermudez, Veronica, Wey, Etienne, Marchand-Lasserre, Mathilde, Saboret, Laurent

    ISSN: 1932-6203, 1932-6203
    Published: United States Public Library of Science 07.09.2022
    Published in PloS one (07.09.2022)
    “…A growing number of studies suggest that climate may impact the spread of COVID-19. This hypothesis is supported by data from similar viral contagions, such as…”
    Get full text
    Journal Article
  13. 13

    Case Report: Post-Partum SARS-CoV-2 Infection After the First French Uterus Transplantation by Ayoubi, Jean Marc, Carbonnel, Marie, Kvarnström, Niclas, Revaux, Aurelie, Poulain, Marine, Vanlieferinghen, Sarah, Coatantiec, Yves, Le Marchand, Mathilde, Tourne, Morgan, Pirtea, Paul, Snanoudj, Renaud, Le Guen, Morgan, Dahm-Kähler, Pernilla, Racowsky, Catherine, Brännström, Mats

    ISSN: 2296-875X, 2296-875X
    Published: Frontiers Media S.A 28.06.2022
    Published in Frontiers in surgery (28.06.2022)
    “…Absolute uterus factor infertility, whether congenital or acquired, renders the woman unable to carry a child. Although uterus transplantation (UTx) is being…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting by Morrissey, Kari M., Marchand, Mathilde, Patel, Hina, Zhang, Rong, Wu, Benjamin, Phyllis Chan, H., Mecke, Almut, Girish, Sandhya, Jin, Jin Y., Winter, Helen R., Bruno, René

    ISSN: 0344-5704, 1432-0843, 1432-0843
    Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2019
    Published in Cancer chemotherapy and pharmacology (01.12.2019)
    “…Purpose To determine the exposure–response (ER) relationships between atezolizumab exposure and efficacy or safety in patients with advanced non-small cell…”
    Get full text
    Journal Article
  17. 17

    Tumor Growth Inhibition-Overall Survival Subgroup Analysis of Atezolizumab in the IMpower150 Study by Yoshida, Kenta, Chan, Phyllis, Marchand, Mathilde, Zhang, Rong, Wu, Benjamin, Ballinger, Marcus, Sternheim, Nitzan

    ISSN: 1550-7416, 1550-7416
    Published: Springer 01.05.2022
    Published in The AAPS journal (01.05.2022)
    “…Longitudinal changes of tumor size or tumor-associated biomarkers have been receiving growing attention as early markers of treatment benefits. Tumor growth…”
    Get full text
    Journal Article
  18. 18

    Secondary alveolar bone grafting of clefts using bioactive glass 45S5: Long-term dental and periodontal status by Verdier, Emmanuelle, Azzis, Olivier, Marchand, Mathilde, Jeanne, Sylvie, Lebullenger, Ronan, Gatibelza, Marie Eve, Davit-Béal, Tiphaine, Brézulier, Damien

    ISSN: 0889-5406, 1097-6752, 1097-6752
    Published: United States Elsevier Inc 01.09.2025
    “…Secondary alveolar bone grafting (SABG) restores the continuity of alveolar bone in orofacial clefts to establish a functional dental occlusion. Given the…”
    Get full text
    Journal Article
  19. 19

    Population pharmacokinetics of bevacizumab in cancer patients with external validation by Han, Kelong, Peyret, Thomas, Marchand, Mathilde, Quartino, Angelica, Gosselin, Nathalie H., Girish, Sandhya, Allison, David E., Jin, Jin

    ISSN: 0344-5704, 1432-0843, 1432-0843
    Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2016
    Published in Cancer chemotherapy and pharmacology (01.08.2016)
    “…Background Bevacizumab is approved for various cancers. This analysis aimed to comprehensively evaluate bevacizumab pharmacokinetics and the influence of…”
    Get full text
    Journal Article
  20. 20

    Modelling recycling for the life cycle assessment of perovskite/silicon tandem modules by Wang, Lu, Oberbeck, Lars, Marchand, Mathilde, Perez-Lopez, Paula

    ISSN: 2105-0716, 2105-0716
    Published: EDP sciences 2024
    Published in EPJ Photovoltaics (2024)
    “…With the massive growth of the global capacity of photovoltaics (PV) over the last decade, the PV waste is expected to increase dramatically in the near…”
    Get full text
    Journal Article